Log In
Print
BCIQ
Print
Print this Print this
 

Adjuvanted Influenza A (H5N1) Virus Monovalent Vaccine (Q-Pan H5N1 adjuvanted)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionEgg-based injectable adjuvanted influenza vaccine containing AS03 adjuvant
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentApproved
Standard IndicationInfluenza virus
Indication DetailsPrevent disease in adults who are at an increased risk of exposure to the influenza A virus subtype H5N1
Regulatory Designation

U.S. - Undisclosed Review (Prevent disease in adults who are at an increased risk of exposure to the influenza A virus subtype H5N1)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today